Di Biagio, Anna
 Distribuzione geografica
Continente #
NA - Nord America 143
EU - Europa 94
AS - Asia 31
AF - Africa 1
Totale 269
Nazione #
US - Stati Uniti d'America 143
SE - Svezia 37
IT - Italia 26
SG - Singapore 17
DE - Germania 8
IE - Irlanda 7
CN - Cina 6
FR - Francia 6
ID - Indonesia 6
LT - Lituania 3
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
FI - Finlandia 1
GB - Regno Unito 1
IN - India 1
IR - Iran 1
RU - Federazione Russa 1
Totale 269
Città #
Chandler 47
Singapore 16
New York 12
Rome 11
Ashburn 9
Milan 8
Chicago 7
Dublin 7
Wilmington 7
Jakarta 6
San Mateo 6
Bremen 5
Princeton 5
Boston 4
Falls Church 4
Marseille 4
Tavagnacco 4
Los Angeles 2
Vilnius 2
Abidjan 1
Andover 1
Augusta 1
Berlin 1
Boardman 1
Brno 1
Brussels 1
Dongguan 1
Fairfield 1
Frankfurt am Main 1
Greenlawn 1
Kish 1
Lappeenranta 1
Moscow 1
Norwalk 1
Pisa 1
Santa Clara 1
Seattle 1
Washington 1
Zurich 1
Totale 186
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 60
An explainable model of host genetic interactions linked to COVID-19 severity 50
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 49
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 45
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results 45
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 30
Totale 279
Categoria #
all - tutte 1.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 2 0
2020/20213 0 0 0 0 0 0 0 0 2 1 0 0
2021/202247 1 0 0 2 2 1 12 10 2 1 9 7
2022/2023134 19 18 7 20 7 13 6 6 13 24 1 0
2023/202460 2 18 2 4 3 17 1 2 0 1 3 7
2024/202533 1 1 10 6 15 0 0 0 0 0 0 0
Totale 279